This list is based on the watchlists of people on Stock Events who follow XI3.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company's products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Show more...
FAQ
What is BIOCELTIX. stock price today?▼
The current price of XI3.F is €17.62 EUR — it has decreased by -0.34% in the past 24 hours. Watch BIOCELTIX. stock price performance more closely on the chart.
What is BIOCELTIX. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BIOCELTIX. stocks are traded under the ticker XI3.F.
Is BIOCELTIX. stock price growing?▼
XI3.F stock has risen by +2.8% compared to the previous week, the month change is a +23.74% rise, over the last year BIOCELTIX. has showed a -25.5% decrease.
What is BIOCELTIX. market cap?▼
Today BIOCELTIX. has the market capitalization of 86.76M
What is BIOCELTIX. revenue for the last year?▼
BIOCELTIX. revenue for the last year amounts to 0 EUR.
What is BIOCELTIX. net income for the last year?▼
XI3.F net income for the last year is -6.96M EUR.
How many employees does BIOCELTIX. have?▼
As of April 29, 2026, the company has 41 employees.
In which sector is BIOCELTIX. located?▼
BIOCELTIX. operates in the Health & Wellness sector.
When did BIOCELTIX. complete a stock split?▼
BIOCELTIX. has not had any recent stock splits.
Where is BIOCELTIX. headquartered?▼
BIOCELTIX. is headquartered in Wroclaw, Poland.